IPO of China's Mindray shows increase, interest

China-based Mindray Medical International Ltd., which produces ultrasound equipment, patient monitoring devices and diagnostic lab instruments, doubled its income in the first half of the year to $20.6 million from a year earlier and says it has the market lead for monitoring equipment in China. In an IPO underwritten by Goldman Sachs Group and UBS AG, each of whom own some of the stock, shares rose 30% in the first day of trading.

View Full Article in:

MarketWatch · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA